Find News

Filter articles

Showing 3501 to 3510 of 3629 results

Californian governor vetoes biosimilars bill


The governor of California, Jerry Brown, has refused to sign legislation seeking to introduce changes to the state’s pharmacy law on biosimilars.

Arnold clears conflict of interest in SPC trial


Mr Justice Arnold has refused to recuse himself from a patent trial after he was accused of being conflicted by an expert witness.

C.R. Bard secures $1 billion damages in patent victory


The US District Court for the District of Arizona has rejected technology company W.L. Gore’s motion for a new trial to amend the judgment of its patent dispute with medical device maker C.R. Bard.

Hacon to fill Birss’s shoes at UK court


British barrister Richard Hacon is set to become the permanent presiding judge of the Intellectual Property Enterprise Court, multiple sources have told WIPR.

AstraZeneca adds to cancer drug portfolio


UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen.

Radcliffe leaves Mayer Brown for Charles Russell


Patent litigator Jonathan Radcliffe has left Mayer Brown to become partner at Charles Russell LLP.

Federal Circuit says no to “Prevail” trademark


The US Court of Appeals for the Federal Circuit has denied a US company’s bid to trademark “Prevail” for medical devices used to treat obesity.

Bayer takes another swipe at Nexavar compulsory licence

India15-10-2013Legal developments

Bayer has appealed against the IPAB’s compulsory licence order that allows domestic generic maker Natco Pharma to market its own version of liver and kidney cancer drug Nexavar, this time at the Mumbai High Court.

Trevor Cook to leave Bird & Bird for WilmerHale

UK, US15-10-2013

After 39 years at the firm, IP litigator Trevor Cook will be leaving UK-based Bird & Bird LLP to join Wilmer Cutler Pickering Hale and Dorr LLP in New York.

Myriad hit with gene testing suit


US biotech company Myriad Genetics is facing claims that 14 of its patents covering tests for breast and ovarian cancer are invalid and non-infringed by Quest Diagnostics.

Showing 3501 to 3510 of 3629 results